Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 28, 2014 - Issue 14
141
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

The semisynthetic spin-labelled derivatives of 3-hydroxybutanolide as potential oxidative stress inhibitors

, , , &
Pages 1037-1044 | Received 06 Nov 2013, Accepted 09 Mar 2014, Published online: 04 Apr 2014
 

Abstract

To obtain more accessible oxidative stress inhibitors, a series of novel spin-labelled derivatives of 3-hydroxybutanolide (2ad, 3ad) with the natural active compound (kinsenoside) as the lead compound were designed, synthesised from the nitroxide free radical piperidine (pyrroline) and the main structural unit of kinsenoside: 3-hydroxybutanolide. Antioxidant activity screening of these derivatives was performed using MTT method on rat pheochromocytoma PC12 cells. The antioxidative stress effect was further investigated on the changes of the important antioxidant enzyme activities and intracellular reactive oxygen species production. Among the derivatives, 2bd, 3a and 3c showed comparable or superior antioxidative stress activity to kinsenoside. Also, most of the tested derivatives displayed obvious antioxidative ability in concentrations. Cytotoxic assay simultaneously indicated that all compounds had very low toxicity to normal cells. Based on the observed results, the structure–activity relationship of these derivatives was discussed.

Acknowledgements

This work was supported by the grants from the National Natural Science Foundation of China (No. 20972061), the National Fundamental Fund for Personnel Training (No. J1103307) and Fujian Province Natural Science Foundation of China (No. 2013J01337).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.